Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Star Diamond: High Modelled Diamond Prices and High Proportions of Type IIa Diamonds (click to learn more) Northstar Discovers Large Near Surface EM Conductor SE of Cam Copper Mine (click to learn more) Xcyte Digital Corp. Releases "Xperience" Subscription Service (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Briacell Therapeutics Corp. T.BCT

Alternate Symbol(s):  BCTX | BCTXW

Healthcare Biotechnology
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops immunotherapies to transform cancer care. The Company’s lead drug candidate, Bria-IMT, is a cell-based patented immunotherapy that stimulates a patient’s own cancer fighting cells to attack and destroy breast cancer tumors. The Company is advancing its targeted immunotherapy program by prioritizing a Phase II... see more

Recent & Breaking News (TSX:BCT)

BriaCell Discovers Gene Signature of BriaVax(TM) Cancer Vaccine Consistent With Exceptional Efficacy in Clinical Trial

Marketwired March 29, 2016

BriaCell Announces Senior Management Change

Marketwired March 24, 2016

BioNap Consulting's Jason Napodano Interviewed by The Life Sciences Report

Marketwired December 18, 2015

IIROC Trading Resumption - BCT

Canada NewsWire November 4, 2015

IIROC Trade Resumption - BriaCell Therapeutics Corp.

Newsfile November 4, 2015

BriaCell Receives FDA Authorization to Initiate Phase I/IIa Trial of Cell-Based Immunotherapy BriaVax(TM) in Advanced Breast Cancer Patients

Marketwired November 4, 2015

IIROC Trade Halt - BriaCell Therapeutics Corp.

Newsfile November 4, 2015

IIROC Trading Halt - BCT

Canada NewsWire November 4, 2015

BriaCell Therapeutics to Present at 14th Annual BIO Investor Forum in San Francisco

Marketwired October 19, 2015

BriaCell Therapeutics Successfully Advances Towards Initiation of BriaVax(TM) Phase I/IIa Clinical Trial

Marketwired October 8, 2015

BriaCell Executives Interviewed by The Life Sciences Report

Marketwired October 1, 2015

BriaCell Launches Development of Companion Diagnostic Product, BriaDx(TM)

Marketwired September 14, 2015

Immuno-Oncology Biotech BriaCell Attracts Top Scientist to Head R&D

Marketwired July 15, 2015

BriaCell Therapeutics Begins Trading on the OTCQB (ANCCF) and Presents at a New York Biotech Investor Conference

Marketwired June 24, 2015

BriaCell Therapeutics Announces Positive Response From FDA and Entry Into a Definitive Agreement to Begin GMP Manufacturing of BriaVax

Marketwired June 16, 2015

BriaCell Therapeutics Announces New President, CEO and Chairman of the Board

Marketwired June 1, 2015

BriaCell to Partner With Top U.S. Medical Institution Washington University to Produce Its BriaVax(TM) Cancer Vaccine

Marketwired May 27, 2015

BriaCell Therapeutics Successfully Completes Testing Requested by FDA

Marketwired May 19, 2015

BriaCell Therapeutics Submits Phase-I/II Protocol to the US FDA

Marketwired March 10, 2015

BriaCell Therapeutics to Present at the 2015 BIO CEO and Investor Conference

Marketwired February 4, 2015